More on ZVRA

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-15.8% Growth)
- Ratings (10.0 Score)

Upcoming Events

- Earnings (11/11/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Zevra Therapeutics (NQ:ZVRA)
Delayed: 12.06 --0 (-0%)
Prev. Close $12.06  
Open$12.06 
52 Wk High$ 
52 Wk Low$ 
Day High$12.06 
Day Low$12.06 
P/E N/A  
EPS$ 
Volume2,100 

Friends, Peers and Foes (?): WGS (more...)

Aug 21, 2026 04:30 PM Zevra Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Aug 20, 2026 06:59 AM H.C. Wainwright Reiterates Buy Rating on Zevra Therapeutics, Inc. (ZVRA)
Aug 17, 2026 04:33 PM Form 4 ZEVRA THERAPEUTICS, INC. For: Aug 14 Filed by: Thompson Rahsaan
Aug 14, 2026 04:35 PM Form 144 ZEVRA THERAPEUTICS, INC. Filed by: Thompson Rahsaan
Aug 14, 2026 11:06 AM Form SCHEDULE 13G/A ZEVRA THERAPEUTICS, INC. Filed by: Woodline Partners LP
Aug 12, 2026 04:17 PM Form 4 ZEVRA THERAPEUTICS, INC. For: Aug 10 Filed by: Watton Corey Michael
Aug 6, 2026 10:48 AM Form SCHEDULE 13G/A ZEVRA THERAPEUTICS, INC. Filed by: FMR LLC
Aug 6, 2026 06:31 AM Zevra Therapeutics, Inc. (ZVRA) PT Raised to $28 at Citizens
Aug 5, 2026 05:19 PM Form 10-Q ZEVRA THERAPEUTICS, INC. For: Jun 30
Aug 5, 2026 04:33 PM Zevra Therapeutics, Inc. (ZVRA) Tops Q2 EPS by 3c
View All Articles

Entities mentioned with ZVRA

View All Entities